Potential value of transfusion protocols in cardiac surgery

Current Opinion in Anaesthesiology

Volumn 26, Issue 2, 2013, Pages 230-243

  Görlinger, Klaus ^a   Dirkmann, Daniel ^a   Hanke, Alexander A ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

goal directed therapy; impedance aggregometry; point of care testing; thromboelastometry; transfusion related adverse events

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; LYSINE DERIVATIVE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ALLOGENEIC BLOOD TRANSFUSION; ARTIFICIAL VENTILATION; BLEEDING TENDENCY; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DRUG SAFETY; HEART SURGERY; HEMOSTASIS; HOSPITALIZATION COST; HUMAN; INTENSIVE CARE; LABORATORY TEST; LENGTH OF STAY; POINT OF CARE TESTING; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; REVIEW; TREATMENT DURATION;

BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CLINICAL PROTOCOLS; FACTOR VIIA; FIBRINOGEN; HEMOSTATICS; HUMANS; POINT-OF-CARE SYSTEMS; POSTOPERATIVE HEMORRHAGE; THROMBELASTOGRAPHY;

EID: 84874949613     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32835ddca6     Document Type: Review

References (80)

1. Cobain TJ, Vamvakas EC, Wells A, et al. A survey of the demographics of blood use. Transfus Med 2007; 17:1-15.
2. Goodnough LT, Soegiarso RW, Birkmeyer JD, et al. Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med 1993; 94:509-514.
3. Snyder-Ramos SA, Mö hnle P, Weng YS, et al. The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion 2008; 48:1284-1299.
4. Shander A, Fink A, Javidroozi M, et al. Appropriateness of allogeneic red blood cell transfusion: The international consensus conference on transfusion outcomes. Transfus Med Rev 2011; 25:232-246e53.
5. Stanworth SJ, Grant-Casey J, Lowe D, et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51:62-70.
6. Christensen MC, Dziewior F, Kempel A, et al. Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:46-51.
7. Christensen MC, Krapf S, Kempel A, et al. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg 2009; 138:687-693.
8. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-2552.
9. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36:2667-2674.
10. Reeves BC, Murphy GJ. Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Anaesthesiol 2008; 21:669-673.
11. Bhaskar B, Dulhunty J, Mullany DV, et al. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. Ann Thorac Surg 2012; 94:460-467.
12. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004; 44:1143-1148.
13. Dara SI, Rana R, Afessa B, et al. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005; 33:2667-2671.
14. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131:1308-1314.
15. Sarani B, Dunkman WJ, Dean L, et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008; 36:1114-1118.
16. Welsby IJ, Troughton M, Phillips-Bute B, et al. The relationship of plasma transfusion from female and male donors with outcome after cardiac surgery. J Thorac Cardiovasc Surg 2010; 140:1353-1360.
17. Bjursten H, Dardashti A, Ederoth P, et al. Increased long-term mortality with plasma transfusion after coronary artery bypass surgery. Intensive Care Med 2012 [Epub ahead of print].
18. Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011; 11:135.
19. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011: CD001886.
20. Hutton B, Joseph L, Fergusson D, et al. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345:e5798.
21. Koster A, Schirmer U. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Curr Opin Anaesthesiol 2011; 24:92-97.
22. Casbard AC, Williamson LM, Murphy MF, et al. The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review. Anaesthesia 2004; 59:550-558.
23. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46:1279-1285.
24. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126:133-139.
25. Stanworth SJ, Walsh TS, Prescott RJ, et al. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15:R108.
26. Gill R, Herbertson M, Vuylsteke A, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120:21-27.
27. Levi M, Levy JH, Andersen HF, et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363:1791-1800.
28. Rahe-Meyer N, Winterhalter M, Hartmann J, et al. An evaluation of cyclooxygenase-1 inhibition before coronary artery surgery: Aggregometry versus patient self-reporting. Anesth Analg 2008; 107:1791-1797.
29. Velik-Salchner C, Maier S, Innerhofer P, et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg 2009; 108:1747-1754.
30. Rahe-Meyer N, Winterhalter M, Boden A, et al. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaesthesiol Scand 2009; 53:168-175.
31. Sibbing D, Schulz S, Braun S, et al. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 2010; 8:250-256.
32. Sibbing D, SteinhublSR, Schulz S, et al. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. J Am Coll Cardiol 2010; 56:317-318.
33. Emeklibas N, Kammerer I, Bach J, et al. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery. Transfusion 2012. doi: 10.1111/j.1537-2995.2012. 03885.x [Epub ahead of print].
34. Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012; 5:261-269.
35. Lee GC, Kicza AM, Liu KY, et al. Does rotational thromboelastometry (ROTEM) improve prediction of bleeding after cardiac surgery? Anesth Analg 2012; 115:499-506.
36. Karlsson M, Ternström L, Hyllner M, et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008; 48:2152-2158.
37. Ternström L, Radulovic V, Karlsson M, et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res 2010; 126:e128-e133.
38. Reinhö fer M, Brauer M, Franke U, et al. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19:212-219.
39. Gö dje O, Gallmeier U, Schelian M, et al. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54:26-33.
40. Karkouti K, McCluskey SA, Syed S, et al. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Anesth Analg 2010; 110:1533-1540.
41. Mittermayr M, Velik-Salchner C, Stalzer B, et al. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Anesth Analg 2009; 108:743-750.
42. Casonato A, Sponga S, Pontara E, et al. von Willebrand factor abnormalities in aortic valve stenosis: pathophysiology and impact on bleeding. Thromb Haemost 2011; 106:58-66.
43. Haas T, Spielmann N, Mauch J, et al. Comparison of thromboelastometry (ROTEM1) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108:36-41.
44. Haas T, Spielmann N, Mauch J, et al. Reproducibility of thrombelastometry (ROTEM(1)): Point-of-care versus hospital laboratory performance. Scand J Clin Lab Invest 2012; 72:313-317.
45. Gö rlinger K, Dirkmann D, Solomon C, et al. Fast interpretation of thromboelastometry in noncardiac surgery: Reliability in patients with hypo-, normo-, and hypercoagulability. Br J Anaesth 2012. doi: 10.1093/bja/aes374 [Epub ahead of print].
46. Dirkmann D, Gö rlinger K, Dusse F, et al. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: A step toward earlier decision making. Acta Anaesth Scand 2012. doi: 10.1111/aas.12040 [Epub ahead of print].
47. Gö rlinger K, Jambor C, Hanke AA, et al. Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis. Transfus Med Hemother 2007; 34:396-411.
48. Larsen OH, Fenger-Eriksen C, Christiansen K, et al. Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology 2011; 115:294-302.
49. Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012; 52:14-22.
50. Gö rlinger K, Bergmann L, Dirkmann D. Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 2012; 26:179-198.
51. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009; 102:785-792.
52. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009; 138:694-702.
53. Gö rlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115:1179-1191.
54. Gö rlinger K, Fries D, Dirkmann D, et al. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus MedHemother 2012; 39:104-113.
55. Lee SH, Lee SM, Kim CS, et al. Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass. Blood Coagul Fibrinolysis 2010; 21:687-691.
56. Rafiq S, Johansson PI, Ostrowski SR, et al. Hypercoagulability in patients undergoing coronary artery bypass grafting: Prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012; 41:550-555.
57. Weber CF, Dietrich W, Spannagl M, et al. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Anesth Analg 2010; 110:702-707.
58. Weber CF, Gö rlinger K, Byhahn C, et al. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol 2011; 28:57-62.
59. Spiess BD, Gillies BS, Chandler W, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9:168-173.
60. Anderson L, Quasim I, Soutar R, et al. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006; 16:31-39.
61. Spalding GJ, Hartrumpf M, Sierig T, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of 'bedside' thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007; 31:1052-1057.
62. Hanke AA, Herold U, Dirkmann D, et al. Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requiremewnts, adverse events, and costs in acute Type A aortic dissection: a pilot study. Transfus Med Hemother 2012; 39:121-128.
63. Avidan MS, Alcock EL, Da Fonseca J, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92:178-186.
64. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastographyguided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319.
65. Manikappa S, Mehta Y, Juneja R, et al. Changes in transfusion therapy guided by thromboelastograph in cardiac surgery. Ann Card Anaesth 2001; 4:21-27.
66. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575-578.
67. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94:773-781.
68. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg 2009; 24:404-410.
69. Westbrook AJ, Olsen J, Bailey M, et al. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ 2009; 18:277-288.
70. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010; 140:1117-1124e2.
71. Weber CF, Gö rlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547.
72. Afshari A, Wikkelsø A, Brok J, et al. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011: CD007871.
73. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012; 26:1-13.
74. Gö rlinger K, Dirkmann D, Weber CF, et al. Algorithms for transfusion and coagulation management in massive haemorrhage. Anä sth Intensivmed 2011; 52:145-159.
75. Gö rlinger K. Coagulation management during liver transplantation. Hämostaseologie 2006; 26:S64-76.
76. Karlsson M, Ternström L, Hyllner M, et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102:137-144.
77. Kozek-Langenecker S, Sørensen B, Hess JR, et al. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15:R239.
78. Sørensen B, Spahn DR, Innerhofer P, et al. Clinical review: Prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011; 15:201.
79. Alexander A Hanke, Christine Joch, Klaus Gö rlinger. Long-term safety and efficacy of a pasteurised nanofiltrated prothrombin complex concentrate (Beriplex P/N). Brit J Anaesth 2012. doi: 10.1093/bja/aes501.
80. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: An updated European guideline. Crit Care 2013; 16.